CD25 recruits inhibitory phosphatases for feedback control of B-cell receptor signaling
نویسندگان
چکیده
Abstract Successful initiation of the B-cell receptor (BCR) signaling, and subsequent antigen-encounter in germinal centers are both marked by sharp increases CD25 surface-expression. Likewise, oncogenic signaling leukemia (B-ALL) lymphoma induces CD25-surface expression. While is known as an IL2-receptor chain on T- NK-cells, significance its expression B-cells was unclear. We discovered that, rather than functioning chain, expressed feedback regulates BCR-signaling or mimics. Recapitulating phenotypes genetic ablation PKCD, SHIP1 SHP1, conditional CD25-deletion suppressed early development but induced hyperactivation antigen-experienced autoimmunity. Additionally, B-cell-specific deletion resulted formation spontaneous expansion autoreactive B cells. Biochemical interactome studies revealed that PKCd-dependent CD25-phosphorylation cytoplasmic tail (S268) to recruit inhibitory phosphatases BCR complex. Upon CD25-deletion, SHP1 were no longer recruited activated limit duration strength BCR-signaling. Loss phosphatase-function, autonomous Ca 2+-oscillations anergy negative selection during development, opposed proliferation autoantibody production B-cells. These findings highlight previously unrecognized role assembling prevent chronic safeguard cell tolerance.
منابع مشابه
Negative Signaling Pathways of the Killer Cell Inhibitory Receptor and FcγRIIb1 Require Distinct Phosphatases
Inhibition of natural killer (NK) cells by the killer cell inhibitory receptor (KIR) involves recruitment of the tyrosine phosphatase SHP-1 by KIR and is prevented by expression of a dominant negative SHP-1 mutant. Another inhibitory receptor, the low affinity Fc receptor for immunoglobulin G (IgG) (Fc gamma RIIb1), has been shown to bind SHP-1 when cocross-linked with the antigen receptor on B...
متن کاملTerminating B cell receptor signaling
Bruton’s tyrosine kinase (BTK) mediated signaling is critical for B cell development and activation. The physiological role of BTK is evident since its functional loss results in a differentiation block of B cells beyond the pro-B cell stage causing X-linked agammaglobulinemia. Inhibitors of BTK, such as ibrutinib and acalabrutinib profoundly impair BCR signaling. They are highly effective in t...
متن کاملA balance between B cell receptor and inhibitory receptor signaling controls plasma cell differentiation by maintaining optimal Ets1 levels.
Signaling through the BCR can drive B cell activation and contribute to B cell differentiation into Ab-secreting plasma cells. The positive BCR signal is counterbalanced by a number of membrane-localized inhibitory receptors that limit B cell activation and plasma cell differentiation. Deficiencies in these negative signaling pathways may cause autoantibody generation and autoimmune disease in ...
متن کاملIgβ tyrosine residues contribute to the control of B cell receptor signaling by regulating receptor internalization
Immunoglobulin (Ig)alpha and Igbeta initiate B cell receptor (BCR) signaling through immune receptor tyrosine activation motifs (ITAMs) that are targets of SH2 domain-containing kinases. To examine the function of Igbeta ITAM tyrosine resides in mature B cells in vivo, we exchanged these residues for alanine by gene targeting (Igbeta(AA)). Mutant mice showed normal development of all B cell sub...
متن کاملFCRL3, an autoimmune susceptibility gene, has inhibitory potential on B-cell receptor-mediated signaling.
A polymorphism that up-regulates the expression of Fc receptor-like 3 (FCRL3) gene has recently been described as predisposing for several human autoimmune diseases. FCRL3 is preferentially expressed on B cells and is unique in displaying both an ITAM and an ITIM in the cytosolic domain, suggesting signaling functions. Herein, we show that FCRL3 potentially inhibits BCR-mediated signaling, usin...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Immunology
سال: 2023
ISSN: ['1550-6606', '0022-1767']
DOI: https://doi.org/10.4049/jimmunol.210.supp.154.23